Showing results (101-110 of 323) with videos related to
Sort By:
Pageof 33
Science (New York, N.Y.)|November 3, 2018
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBNQuinlan L Sievers, Georg Petzold, Richard D Bunker, et al.Nature Biotechnology|June 23, 2014
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editingDirk Heckl, Monika S Kowalczyk, David Yudovich, et al.Nature Biotechnology|September 4, 2014
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivationJohn G Doench, Ella Hartenian, Daniel B Graham, et al.JAMA Cardiology|June 9, 2021
Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular EventsRomit Bhattacharya, Seyedeh Maryam Zekavat, Md Mesbah Uddin, et al.The New England Journal of Medicine|July 1, 2011
Clinical effect of point mutations in myelodysplastic syndromesRafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, et al.Blood|October 5, 2014
Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasmsEdwin Chen, Rebekka K Schneider, Lawrence J Breyfogle, et al.Genome Research|October 3, 2015
Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cellsMonika S Kowalczyk, Itay Tirosh, Dirk Heckl, et al.Nature Communications|January 19, 2020
Rapid and deep-scale ubiquitylation profiling for biology and translational researchNamrata D Udeshi, Deepak C Mani, Shankha Satpathy, et al.Science (New York, N.Y.)|February 9, 2013
(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversibleJulie-Aurore Losman, Ryan E Looper, Peppi Koivunen, et al.Science (New York, N.Y.)|December 17, 2013
Genome-scale CRISPR-Cas9 knockout screening in human cellsOphir Shalem, Neville E Sanjana, Ella Hartenian, et al.Pageof 33